Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2008.429 | Hierarchy of Protective T Cell Response in Patients Infected by Heptitis B Virus | CHAN LY Henry |
| 2007.229 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
| 2007.228 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
| 2005.341 | A Phase I, Multi-Centre, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Local and Systemic Tolerability of the Therapeutic DNA Plasmid pdpSC18 Vaccine Administered by Particle Mediated Epidermal Delivery Using the PowderJect ND10 Delivery System in Subjects with Chronic Hepatitis B Infection | Prof. Chan LY Henry |
| 2006.326 | Validation of Transient Elastography (Fibroscan) with Liver Histology and Morphometry for the Assessment of Liver Fibrosis | Prof. Chan LY Henry |
| 2006.362 | Viral Genomic Predictors of Response to Adefovir Dipivoxil in Chronic Hepatitis B Patients with Lamivudine Resistance | CHAN LY Henry |
| 2003.137 | Switching from Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Multinational Assessment of Treatment Preference | Dr. Chan Lung Wai |
| 2002.073 | Effect of Topical Vaginal Estrogen on Pelvic Floor Dysfunction for Postmenopausal Women: A Double Blind Randomized Control Trial | Prof. Chan Lin Wai Daniel |
| 2011.284 | A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with peg-IFN | Prof. Chan Lik Yuen Henry |
| 2007.206 | A Comparative Study of Entecavir vs Adefovir plus Lamivudine vs Combination Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study | Prof. Chan Lik Yuen Henry |
| 2005.458 | Hepatitis B Virus DNA and Liver-related Complications | CHAN Lik Yuen Henry |
| 2006.330 | Effect of Short-Term Corticosteroid on the Viral Kinetics of Hepatitis B Virus in Patients with Exacerbation of Chronic Obstructive Pulmonary Disease | CHAN Lik Yuen Henry |
| 2003.148 | A Multinational Phase 2 Study of LY582563 in the Treatment of Patients with Chronic Hepatitis B Viral Infection | Prof. Chan Lik Yuen Henry |
| 2004.332 | Double-blinded, Randomized Trial of Thymosin-alfa-1 and Peginterferon alfa-2a (40 KD) (PEGASYS_) Combination Therapy versus Peginterferon Alfa-2a (40 KD) (PEGASYS_) Monotherapy in the Treatment of Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
| 2004.304 | A Randomized, Open Label Trial of Telbivudine (LdT) versus Adefovir Dipivoxil in Adults with HBeAg-Positive, Compensated Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
| 2005.048 | Treatment with Peginterferon Alfa-2a (40 KD) (PEGASYS_) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment | Prof. Chan Lik Yuen Henry |
| 2007.203 | Virological Monitoring of Anti-Viral Treatment in Chronic Hepatitis B | CHAN lik Yuen Henry |
| 2005.028 | A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
| 2004.303 | Combination Treatment of Peginterferon alfa-2b (PegIntron | Prof. Chan Lik Yuen Henry |
| 2007.369 | Hong Kong Hepatitis B Women Patients' Concerns Survey | CHAN Lik Yuen Henry |
| 2007.368 | Public Awareness of Chronic Hepatits B | CHAN Lik Yuen Henry |
| 2002.338 | A Study on the Viral Kinetics of Different Regimes of Pegylated Interferon and Lamivudine Combination Theerpy in HBeAg Positive Chronic Hepatitis B (Revised : cre-2002.203-t) | Prof. Chan Lik Yuen Henry |
| 2006.297 | Surveillance for Early Liver Cirrhosis in Chronic Hepatitis B Patients in Hong Kong Using Transient Elastography | CHAN Lik Yuen Henry |
| 2013.264 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Prof. Chan Lik Yuen Henry |
| 2006.039 | Long-Term Follow-up of Patients Who Completed Serono Protocol 23744 for the Treatment of Chronic Hepatitis C Using Interferon-Beta-1a | CHAN Lik Yuen Henry |
| 2005.279 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Indenix-Sponsored Telbivudine Studies | Prof. Chan Lik Yuen Henry |
| 2005.428 | Intrahepatic Assessment of Hepatitis B Virus in Hepatocellular Carcinoma | CHAN Lik Yuen Henry |
| 2007.352 | The Role of Hepatitis B Virus Encoded MicroRNAs | CHAN Lik Yuen Henry |
| 2007.353 | Use of Serum Hepatitis B Surfact Antigen Quantitation to Monitor Treatment Response in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2003.149 | A Long-Term Observation Study of Safety, Efficacy, and Viral Resistance with LY582563: A Multinational Extension Study in Chronic Hepatitis B-Infected Patients | Prof. Chan Lik Yuen Henry |
| 2006.427 | Effect of Alanine Aminotransamine Levels on the Liver Stiffness Measurement by Transient Elastography (Fibroscan) in Viral Hepatitis | CHAN Lik Yuen Henry |
| 2009.438 | Association of serum hepatitis B surface antigen level with the risk of hepatocellular carcinoma | CHAN Lik Yuen Henry |
| 2012.216 | Risk of advanced colorectal neoplasm in patients with non-alcoholic fatty liver disease | CHAN Lik Yuen Henry |
| 2004.344 | Proteomic Profiling of Liver Fibrosis in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2004.336 | Role of Hepatitis B Virus Covalently Closed Circular DNA in Determination of Treatment Outcome | CHAN Lik Yuen Henry |
| 2010.071 | Presictive value of week 24 response for long-term outcomes of entecavir therapy in patients with chronic hepatitis B | CHAN Lik Yuen Henry |
| 2010.144 | The impact of drug resistance testing in the management of patients with chronic hepatitis B on antiviral therapy - A retrospective study and survey | CHAN Lik Yuen Henry |
| 2009.487 | Evaluation of 3' deleted HBx mutant as a serum marker to predict hepatocellular carcinoma in chronic hepatitus B | CHAN Lik Yuen Henry |
| 2004.426 | Interface of Diagnostic Method Between Chinese and Western Medicine in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2009.242 | Viral Genomic Determinatns of Liver Fibrosis in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2009.318 | Health Related Quality of Life in Patients with Chronic Hepatitis C in Hong Kong | CHAN Lik Yuen Henry |
| 2011.426 | The use of serum interleukin-6 and interleukin-10 in prognostication of advanced hepatocellular carcinoma | CHAN Lam Stephen |
| 2010.356 | A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib | Dr. Chan Lam Stephen |
| 2010.205 | Prospective randomized double-blind placebo controlled trial to assess the role of lamivudine in patients with hepatitis B related-hepatocellular carcinoma not suitable for oncologic therapy due to poor liver function | Prof. Chan Lam Stephen |
| 2007.077 | Noise Level Measurement at Public Hospitals in Hong Kong | CHAN Lam Lam Anne |
| 2006.131 | Epigenetic Inactivation of Wnt Inhibitoary Factor 1 (WIF-1) in Hepatocellular Carcinoma | CHAN Lam |
| 2004.107 | Reducing Blood Exposures and Sharps-Related Injuries in Operating Theatre | CHAN Lai Sze Connie (No email contact) |
| 2007.322 | A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy versus the Combination of Emtricitabine and Tennofovir DF for the Treatment of Chronic Hepatitis B | Prof. Chan L.Y. Henry |
| 2006.347 | An Open-Label, Multicenter, Randomized Study of Combination Therapy with Oral Telbivudine Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-Positive Patients with Chronic Hepatitis B Who are Lamivudine Resistant | Prof. Chan L.Y. Henry |
| 2004.061 | Role of ERRs in the Development of Prostrate Cancer | CHAN L Franky |
Page 250 of 254.